A CIHR Commercialization Peer Review Committee Information Session is planned for Thursday June 23, 2022, from 12:00 pm to 1:30 pm EDT. The purpose of this session is to give potential applicants to the Commercialization Peer Review Committee of the CIHR Project Grant program (CMZ) an opportunity to hear first-hand about the committee ‘culture’: what aspects are generally well-received by reviewers in CMZ, what factors are considered more important than others, how the committee’s mandate is interpreted, what types of proposals are transferred to or from other committees. Dr. Kathleen Marsman from Borden Ladner Gervais LLP is the current Chair of CMZ and will be available to make comments on these issues and to interact with potential applicants on their questions.
About the Speaker
Kathleen Marsman, PhD, is a registered Canadian and U.S. Patent Agent and a Senior Associate at Borden Ladner Gervais LLP. A Waterloo alum (Biochemistry ‘88), she specializes in patent applications for the life sciences, biotechnology, nutrition and chemistry sectors. She counsels patent applicants on matters of patentability, filing strategy and portfolio management. Her clients include universities, healthcare institutions, start-ups and multinational pharmaceutical and consumer product companies. Learn more about her expertise at https://www.blg.com/en/people/m/marsman-kathleen
Please register here by June 17th. As part of the registration, you will be asked to pre-submit questions to the speaker. For further information, please contact Carly Turnbull, Manager, Centre for Bioengineering and Biotechnology.
Open to the University of Waterloo faculty. Ideally suited to the faculty/researchers in the areas of health and commercialization especially those involved in startups, close ties to companies, or with commercialization ambitions, are encouraged to attend. Participants are encouraged to review the CIHR commercialization criteria beforehand at https://cihr-irsc.gc.ca/e/50439.html